Aurinia Pharmaceuticals I... (AUPH)
NASDAQ: AUPH
· Real-Time Price · USD
8.05
-0.22 (-2.66%)
At close: May 23, 2025, 3:59 PM
8.13
0.99%
After-hours: May 23, 2025, 04:53 PM EDT
-2.66% (1D)
| Bid | 8.02 |
| Market Cap | 1.09B |
| Revenue (ttm) | 247.29M |
| Net Income (ttm) | 39.84M |
| EPS (ttm) | 0.27 |
| PE Ratio (ttm) | 29.81 |
| Forward PE | 10.96 |
| Analyst | Buy |
| Ask | 8.4 |
| Volume | 1,816,301 |
| Avg. Volume (20D) | 1,452,631 |
| Open | 8.35 |
| Previous Close | 8.27 |
| Day's Range | 8.04 - 8.57 |
| 52-Week Range | 5.11 - 10.67 |
| Beta | 1.17 |
About AUPH
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol AUPH
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for AUPH stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts6 months ago
+10.9%
Aurinia Pharmaceuticals shares are trading higher ...
Unlock content with
Pro Subscription
8 months ago
+0.77%
Aurinia Pharmaceuticals shares are trading higher after the company announced a board restructuring consisting of seven members.
